Review
Genetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease

References

• ALBERS, D. S., and BEAL, M. F., 2000, Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. Journal of Neural Transmission, Supplement, 59, 133–154.
   PubMedGoogle Scholar
• ALZHEIMER, A., 1907, Uber eine eigenartige erkrankung der himrinde. Erkrankung der Himrinde. Allgemeine. Zeitschrift fur Psychiatrie (Berlin), 64, 146–148.
   Google Scholar
• ATWOOD, C. S., MOIR, R. D., HUANG, X., SCARPA, R. C., BACARRA, N. M., ROMANO, D. M. et al., 1998, Dramatic aggregation of Alzheimer Abeta by Cu(ii) is induced by conditions representing physio-logical acidosis. Journal of Biological Chemistry, 273, 12817–12826.
   Google Scholar
• ATWOOD, C. S., SCARPA, R. C., HUANG, X., MOIR, R. D., JONES, W. D., FAIRLIE, D. P. et al., 2000, Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta 1–42. Journal of Neurochemistry, 75, 1219–1233.
   Google Scholar
• ATWOOD, C. S., ROBINSON, S. R., and SMITH, M. A., 2002, Amyloid-beta: redox-metal chelator and antioxidant. Journal of Alzheimer's Disease, 4, 203–214.
   PubMed Web of Science ®Google Scholar
• BACON, B. R., and BRITTON, R. S., 1990, The pathology of hepatic iron overload: a free radical-mediated process? Hepatology, 11, 127–137.
   Google Scholar
• BAGCHI, D., GARG, A., KROHN, R. L., BAGCHI, M., TRAN, M. X., and STOHS, S. J., 1997, Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Research Communications in Molecular Pathology and Pharmacology, 95, 179–189.
   PubMed Web of Science ®Google Scholar
• BAGCHI, D., GARG, A., KROHN, R. L., BAGCHI, M., BAGCHI, D. J., BALMOORI, J. et al., 1998, Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. General Pharmacology, 30, 771–776.
   Google Scholar
• BARBER, A. A., 1966, Lipid peroxidation in rat tissue homogenates: interaction of iron and ascorbic acid as the normal catalytic mechanism. Lipids, 1, 146–151.
   PubMed Web of Science ®Google Scholar
• BARBERGER-GATEAU, P., LETENNEUR, L., DESCHAMPS, V., PERES, K., DARTIGUES, J. F., and RENAUD, S., 2002, Fish, meat, and risk of dementia: cohort study. BMJ, 325, 932–933.
   Google Scholar
• BASU, S., 1999, Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochemical and Biophysical Research Communications, 254, 764–767.
   PubMed Web of Science ®Google Scholar
• BEAL, M. F., 1996, Mitochondria, free radicals, and neurodegeneration. Current Opinion in Neurobiology, 6, 661–666.
   PubMed Web of Science ®Google Scholar
• BEHL, C., 1997, Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell and Tissue Research, 290, 471–480.
   PubMed Web of Science ®Google Scholar
• BEHL C., 2000, Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappaB. Journal of Neural Transmission, 107, 393–407.
   PubMed Web of Science ®Google Scholar
• BEHL C., 2002, Oestrogen as a neuroprotective hormone. Nature Reviews, Neuroscience, 6, 433–442.
   Web of Science ®Google Scholar
• BEHL, C., DAVIS, J., COLE, G. M., and SCHUBERT, D., 1992, Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochemical and Biophysical Research Communications, 186, 944–950.
   PubMed Web of Science ®Google Scholar
• BEHL, C., DAVIS, J. B., LESLEY, R., and SCHUBERT, D., 1994, Hydrogen peroxide mediates amyloid beta protein toxicity. Cell, 77, 817–827.
   PubMed Web of Science ®Google Scholar
• BEHL, C., TRAPP, T., SKUTELLA, T., and HOLSBOER, F., 1997, Protection against oxidative stress-induced neuronal cell death — a novel role for ru486. Eur J Neurosci, 9, 912–920.
   PubMed Web of Science ®Google Scholar
• BEHL, C., WIDMANN, M., TRAPP, T., and HOLSBOER, F., 1995, 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochemical and Biophysical Research Communications, 216, 473–482.
   PubMed Web of Science ®Google Scholar
• BENZI, G., and MORETTI, A., 1995, Are reactive oxygen species involved in Alzheimer's disease? Neurobiology of Aging, 16, 661–674.
   Google Scholar
• BISAGLIA, M., VENEZIA, V., PICCIOLI, P., STANZIONE, S., PORCILE, C., Russo, C. et al., 2002, Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochemistry International, 41, 43–54.
   Google Scholar
• BOVERIS, A., and CHANCE, B., 1973, The mitochondrial generation of hydrogen peroxide. General proper-ties and effect of hyperbaric oxygen. Biochemical Journal, 134, 707–716.
   PubMed Web of Science ®Google Scholar
• BRAYNE, C., GILL, C., HUPPERT, F. A., BARKLEY, C., GEHLHAAR, E., GIRLING, D. M., O'CONNOR, D. W. et al., 1998, Vascular risks and incident dementia: results from a cohort study of the very old. Dementia and Geriatric Cognitive Disorders, 9, 175–180.
   Google Scholar
• BREWER, G. J., 1997, Effects of acidosis on the distribution of processing of the beta-amyloid precursor protein in cultured hippocampal neurons. Molecular and Chemical Neuropathology, 31, 171–186.
   PubMedGoogle Scholar
• BREWER, G. J., 1998, Age-related toxicity to lactate, glutamate, and beta-amyloid in cultured adult neurons. Neurobiology of Aging, 19, 561–568.
   PubMed Web of Science ®Google Scholar
• BUSH, A. I., PETTINGELL, W. H., MULTHAUP, G., D PARADIS, M., VONSATTEL, J. P., GUSELLA, J. F. et al., 1994a, Rapid induction of Alzheimer A-beta amyloid formation by zinc. Science, 265, 1464–1467.
   Google Scholar
• BUSH, A. I., PETTINGELL, W. H. JR, DE PARADIS, M., TANZI, R. E., and WASCO, W., 1994b, The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. Journal of Biological Chemistry, 43,26618–26621.
   Google Scholar
• BUTTERFIELD, D. A., 1997, Beta-amyloid-associated free radical oxidative stress and neurotoxicity: impli-cations for Alzheimer's disease. Chemical Research in Toxicology, 10, 495–506.
   PubMed Web of Science ®Google Scholar
• BUTTERFIELD, D. A., CASTEGNA, A., LAUDERBACK, C. M., and DRAKE, J., 2002, Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in alzheimer's disease brain contribute to neuronal death. Neurobiol Aging, 23, 655–664.
   PubMed Web of Science ®Google Scholar
• BUTTERFIELD, D. A., HENSLEY, K., HARRIS, M., MATTSON, M., and CARNEY, J., 1994, Beta-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fash-ion: implications to Alzheimer's disease. Biochemical and Biophysical Research Communications, 200, 710–715.
   PubMed Web of Science ®Google Scholar
• BUXBAUM, J. D., SILVERMAN, J. M., SMITH, C. J., KILIFARSKI, M., REICHERT, J., HOLLANDER, E. et al., 2001, Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. American Journal of Human Genetics, 68, 1514–1520.
   Google Scholar
• CAI, X. D., GOLDE, T. E., and YOUNKIN, S. G., 1993, Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science, 259, 514–516.
   PubMed Web of Science ®Google Scholar
• CANEVARI, L., CLARK, J. B., and BATES, T. E., 1999, Beta-amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Letters, 457, 131–134.
   PubMed Web of Science ®Google Scholar
• CASLEY, C. S., CANEVARI, L., LAND, J. M., CLARK, J. B., and SHARPE, M. A., 2002, Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. Journal of Neurochemistry, 80, 91–100.
   PubMed Web of Science ®Google Scholar
• CASTELLANI, R. J., SMITH, M. A., NUNOMURA, A., HARRIS, P. L., and PERRY, G., 1999, Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radical Biology and Medicine, 26, 1508–1512.
   Google Scholar
• CECCHI, C., FIORILLO, C., SORBI, S., LATORRACA, S., NACMIAS, B., BAGNOLI, S. et al., 2002, Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radical Biology and Medicine, 33, 1372–1379.
   Google Scholar
• CHAN, C., DHARMARAJAN, A., ATWOOD, C., HUANG, X., TANZI, R., BUSH, A. et al., 1999, Anti-apoptotic action of Alzheimer beta amyloid. Alzheimer's Reports, 2, 113–119.
   Google Scholar
• CHANDRA, V., and PANDAV, R., 1998, Gene—environment interaction in Alzheimer's disease: a potential role for cholesterol. Neuroepidemiology, 17, 225–232.
   PubMed Web of Science ®Google Scholar
• CHARTIER-HARLIN, M. C., CRAWFORD, F., HOULDEN, H., WARREN, A., HUGHES, D., FIDANI, L. et al., 1991, Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature, 353, 844–846.
   Google Scholar
• CHEESEMAN, K. H., and SLATER, T. F., 1993, An introduction to free radical biochemistry. British Medical Bulletin, 49, 481–493.
   PubMed Web of Science ®Google Scholar
• CITRON, M., OLTERSDORF, T., HAASS, C., MCCONLOGUE, L., HUNG, A. Y., SEUBERT, P. et al., 1992, Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature, 360, 672–674.
   Google Scholar
• CLEMENTS, A., ALLSOP, D., WALSH, D. M., and WILLIAMS, C. H., 1996, Aggregation and metal-binding properties of mutant forms of the amyloid A-beta peptide of Alzheimer's disease. Journal of Neurochemistry, 66, 740–747.
   PubMed Web of Science ®Google Scholar
• CONNOR, J. R., SNYDER, B. S., BEARD, J. L., FINE, R. E., and MUFSON, E. J., 1992, Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. Journal of Neuroscience Research, 31, 327–335.
   PubMed Web of Science ®Google Scholar
• COPANI, A., KoH, J. Y., and COTMAN, C. W., 1991, Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport, 2, 763–765.
   PubMed Web of Science ®Google Scholar
• CORDER, E. H., SAUNDERS, A. M., STRITTMATTER, W. J., SCHMECHEL, D. E., GASKELL, P. C., SMALL, G. W. et al., 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.
   Google Scholar
• CRAFT, S., ZALLEN, G., and BAKER, L. D., 1992, Glucose and memory in mild senile dementia of the Alzheimer type. Journal of Clinical and Experimental Neuropsychology, 14, 253–267.
   PubMed Web of Science ®Google Scholar
• CRAFT, S., NEWCOMER, J., KANNE, S., DAGOGO-JACK, S., CRYER, P., SHELINE, Y. et al., 1996, Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiology of Aging, 17, 123–130.
   Google Scholar
• CRAWFORD, J. G., 1996, Alzheimer's disease risk factors as related to cerebral blood flow. Medical Hypotheses, 46, 367–377.
   PubMed Web of Science ®Google Scholar
• CUAJUNGCO, M. P., GOLDSTEIN, L. E., NUNOMURA, A., SMITH, M. A., Lim, J. T., ATWOOD, C. S. et al., 2000, Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Abeta by zinc. Journal of Biological Chemistry, 275, 19439–19442.
   Google Scholar
• CZECH, C., FORSTL, H., HENTSCHEL, F., MONNING, U., BESTHORN, C., GEIGER-KABISCH, C. et al., 1994, Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change. European Archives of Psychiatry and Clinical Neuroscience, 243, 291–292.
   Google Scholar
• DAVIES, K. J., 1995, Oxidative stress: the paradox of aerobic life. Biochemical Society Symposia, 61, 1–31.
   PubMedGoogle Scholar
• DAVIS, J. B., 1996, Oxidative mechanisms in beta-amyloid cytotoxicity. Neurodegeneration, 5, 441–444.
   PubMedGoogle Scholar
• DELA MONTE, S. M., and HEDLEY-WHYTE, E. T., 1990, Small cerebral hemispheres in adults with Down's Syndrome: Contributions of developmental arrest and lesions of Alzheimer's disease. Journal of Neuropathology and Experimental Neurology, 49, 509–520.
   Google Scholar
• DE LA TORRE, J. C., 1999, Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathologica (Berlin), 98, 1–8.
   Google Scholar
• DEL MAESTRO, R. F., 1980, An approach to free radicals in medicine and biology. Acta Physiologica Scandinavica, Supplementum, 492, 153–168.
   PubMedGoogle Scholar
• DIAMOND, B. J., SHIFLETT, S. C., FEIWEL, N., MATHEIS, R. J., NOSKIN, O., RICHARDS, J. A. et al., 2000, Ginkgo biloba extract: mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation, 81, 668–678.
   Google Scholar
• DIANZANI, M. U., and UGAZIO, G., 1978, Lipid peroxidation. In Biochemical Mechanisms of Liver Injury edited by T. F. Slater (London: Academic Press), pp. 669–707.
   Google Scholar
• DICKSON, D. W., RUAN, D., CRYSTAL, H., MARK, M. H., DAVIES, P., KRESS, Y. et al., 1991, Hippocampal degeneration differentiates diffuse Lewy Body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology, 41, 1402–1409.
   Google Scholar
• ECKERT, A., HARTMANN, H., and MULLER, W. E., 1993, Beta-amyloid protein enhances the mitogen-induced calcium response in circulating human lymphocytes. FEBS Letters, 330,49–52.
   PubMed Web of Science ®Google Scholar
• EGAN, T. J., ZAK, O., and AISEN, P., 1993, The anion requirement for iron release from transferrin is preserved in the receptor-transferrin complex. Biochemistry, 32, 8162–8167.
   PubMed Web of Science ®Google Scholar
• EHRENWALD, E., CHIsoLm, G. M., and Fox, P. L., 1994, Intact human ceruloplasmin oxidatively modifies low density lipoprotein. Journal of Clinical Investigation, 93, 1493–1501.
   PubMed Web of Science ®Google Scholar
• ESTERBAUER, H., SCHAUR, R. J., and ZOLLNER, H., 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine, 11, 81–128.
   PubMed Web of Science ®Google Scholar
• EVANS, D. A., FUNKENSTEIN, H. H., ALBERT, M. S., SCHERR, P. A., COOK, N. R., CHOWN, M. J. et al., 1989, Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. Journal of the American Medical Association, 262, 2551–2556.
   Google Scholar
• FASSBENDER, K., SIMONS, M., BERGMANN, C., STROICK, M., LUTJOHANN, D., KELLER, P. et al., 2001, Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proceedings of the National Academy of Sciences USA, 98, 5856–5861.
   Google Scholar
• FRANCESCHI, C., CHIRICOLO, M., LICASTRO, F., ZANNOTTI, M., MASI, M., MOCCHEGIANI, E. et al., 1988, Oral zinc supplementation in Down's Syndrome: restoration of thymic endocrine activity and of some immune defects. Journal of Mental Deficiency Research, 32, 169–181.
   Google Scholar
• FRASER, P. E., NGUYEN, J. T., SUREWICZ, W. K., and KIRSCHNER, D. A., 1991, pH-dependent structural transitions of Alzheimer amyloid peptides. Biophysical Journal, 60, 1190–1201.
   PubMed Web of Science ®Google Scholar
• FUNAHASHI, T., FLOYD, R. A., and CARNEY, J. M., 1994, Age effect on brain pH during ischemia/ reperfusion and pH influence on peroxidation. Neurobiology of Aging, 15, 161–167.
   PubMed Web of Science ®Google Scholar
• GARDNER, H. W., 1989, Soybean lipoxygenase-1 enzymically forms both (9S)- and (135)-hydroperoxides from linoleic acid by a pH-dependent mechanism. Biochimica et Biophysica Acta, 1001, 274–281.
   PubMed Web of Science ®Google Scholar
• GASPARINI, L., BENUSSI, L., BIANCHETTI, A., BINETTI, G., CURTI, D., GOVONI, S. et al., 1999, Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts. Neuroscience Letters, 263, 197–200.
   Google Scholar
• GEARING, M., MORI, H. MIRRA, S. S., 1996, Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Annals of Neurology, 39, 395–399.
   PubMed Web of Science ®Google Scholar
• GEDDES, J. F., 1997, What's new in the diagnosis of head injury? Journal of Clinical Pathology, 50, 271–274.
   Google Scholar
• GENAZZANI, A. R., and GAMBACCIANI M., 1999, Hormone replacement therapy: the perspectives for the 21st century. Maturitas, 32, 11–17.
   Google Scholar
• GENOVESI, G., PAOLINI, P., MARCELLINI, L., VERNILLO, E., SALVATI, G., POLIDORI, G. et al., 1996, Relationship between autoimmune thyroid disease and Alzheimer's disease. Panminerva Medica, 38, 61–63.
   Google Scholar
• GENTLEMAN, S., and ROBERTS, G., 1992, Risk factors in Alzheimer's disease. BMJ, 304, 118–119.
   PubMed Web of Science ®Google Scholar
• GIBSON, G., MARTINS, R., BLASS, J., and GANDY, S., 1996, Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sciences, 59, 477–489.
   PubMed Web of Science ®Google Scholar
• GIBSON, G. E., SHEU, K. F., and BLASS, J. P., 1998, Abnormalities of mitochondrial enzymes in Alzheimer disease. Journal of Neural Transmission, 105, 855–870.
   PubMed Web of Science ®Google Scholar
• GLENNER, G. G., and WONG, C. W., 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications, 120, 885–890.
   PubMed Web of Science ®Google Scholar
• GOATE, A., CHARTIER-HARLIN, M. C., MULLAN, M., BROWN, J., CRAWFORD, F., FIDANI, L. et al., 1991, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349, 704–706.
   Google Scholar
• GOLDSTEIN, I. M., KAPLAN, H. B., EDELSON, H. S., and WEISSMANN, G., 1979a, Ceruloplasmin. A scavenger of superoxide anion radicals. Journal of Biological Chemistry, 254, 4040–4045.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN, I. M., KAPLAN, H. B., EDELSON, H. S., and WEISSMANN, G., 1979b, A new function for ceruloplasmin as an acute-phase reactant in inflammation: a scavenger of superoxide anion radicals. Transactions of the Association of American Physicians, 92, 360–369.
   PubMedGoogle Scholar
• GRANT, W. B., 1999, Dietary links to Alzheimer's disease: 1999 update. Journal of Alzheimer's Disease, 1, 197–201.
   PubMedGoogle Scholar
• GRAVES, A. B., LARSON, E. B., EDLAND, S. D., BOWEN, J. D., MCCORMICK, W. C., MCCURRY, S. M. et al., 1996, Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. American Journal of Epidemiology, 144, 760–771.
   Google Scholar
• GRIFFITHS, E. J., and HALESTRAP, A. P., 1993, Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. Journal of Molecular and Cellular Cardiology, 25, 1461–1469.
   PubMed Web of Science ®Google Scholar
• GUO, Z., VIITANEN, M., FRATIGLIONI, L., and WINBLAD, B., 1996, Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ, 312, 805–808.
   PubMed Web of Science ®Google Scholar
• GUTTERIDGE, J. M., and HALLIWELL, B., 1990, The measurement and mechanism of lipid peroxidation in biological systems. Trends in Biochemical Sciences, 15, 129–135.
   PubMed Web of Science ®Google Scholar
• HAASS, C., HUNG, A. Y., SELKOE, D. J., and TEPLOW, D. B., 1994, Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. Journal of Biological Chemistry, 269, 17741–17748.
   PubMed Web of Science ®Google Scholar
• HALEY, R. W., and DIETSCHY, J. M., 2000, Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer disease? Archives of Neurology, 57, 1410–1412.
   Google Scholar
• HALLIWELL, B., 1985, Use of desferrioxamine as a 'probe' for iron-dependent formation of hydroxyl radicals. Evidence for a direct reaction between desferal and the superoxide radical. Biochemical Pharmacology, 34, 229–233.
   PubMed Web of Science ®Google Scholar
• HALLIWELL, B., 1997, Antioxidants and human disease: a general introduction. Nutrition Reviews, 55, S44—S49; disc: S49—S52.
   Google Scholar
• HALLIWELL, B., 1999, Establishing the significance and optimal intake of dietary antioxidants: the bio-marker concept. Nutrition Reviews, 57, 104–113.
   PubMed Web of Science ®Google Scholar
• HALLIWELL, B., and GUTTERIDGE, J. M., 1984, Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical Journal, 219, 1–14.
   PubMed Web of Science ®Google Scholar
• HALLIWELL, B. and GUTTERIDGE, J. M. C. Free Radicals in Biology and Medicine (2nd ed.), Clarenden Press, 1989.
   Google Scholar
• HALLIWELL, B., and GUTTERIDGE, J. M., 1990, Role of free radicals and catalytic metal ions in human disease: an overview. Methods in Enzymology, 186, 1–85.
   PubMed Web of Science ®Google Scholar
• HALLIWELL, B., and GUTTERIDGE, J. M., 1992, Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Letters, 307, 108–112.
   PubMed Web of Science ®Google Scholar
• HALLIWELL, B., GUTTERIDGE, J. M., and CROSS, C. E., 1992, Free radicals, antioxidants, and human disease: where are we now? Journal of Laboratory and Clinical Medicine, 119, 598–620.
   PubMed Web of Science ®Google Scholar
• HANLON, M. C., and SEYBERT, D. W., 1997, The pH dependence of lipid peroxidation using water-soluble azo initiators. Free Radical Biology and Medicine, 23, 712–719.
   PubMed Web of Science ®Google Scholar
• HARDY, J., 1997, The alzheimer family of diseases: many etiologies, one pathogenesis? Proceedings of the National Academy of Sciences USA, 94, 2095–2097.
   PubMed Web of Science ®Google Scholar
• HARDY, J., and ALLSOP, D., 1991, Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in Pharmacological Sciences, 12, 383–388.
   PubMed Web of Science ®Google Scholar
• HARDY, J. A., WESTER, P., WINBLAD, B., GEZELIUS, C., BRING, G., and ERIKSSON, A., 1985, The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. Journal of Neural Transmission, 61, 253–264.
   PubMed Web of Science ®Google Scholar
• HARMAN, D., 1956, Aging: a theory based on free radical and radiation chemistry. Journal of Gerontology, 11, 298–300.
   PubMedGoogle Scholar
• HARMAN, D., 1988, Free radicals in aging. Molecular and Cellular Biochemistry, 84, 155–161.
   PubMed Web of Science ®Google Scholar
• HEDLEY, R., HALLMAYER, J., GROTH, D. M., BROOKS, W. S., GANDY, S. E., and MARTINS, R. N., 2002, Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Annals of Neurology, 51, 795–797.
   PubMed Web of Science ®Google Scholar
• HEININGER, K., 2000, A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events. Reviews in the Neurosciences, 11, 213–328.
   PubMed Web of Science ®Google Scholar
• HENDRIE, H. C., HALL, K. S., Hui, S., UNYERZAGT, F. W., Yu, C. E., LAHIRI, D. K. et al., 1995a, Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Annals of Neurology, 37, 118–120.
   Google Scholar
• HENDRIE, H. C., OSTJNTOKUN, B. O., HALL, K. S., OGUNNIYI, A. O., Hui, S. L., UNYERZAGT, F. W. et al., 1995b, Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. American Journal of Psychiatry, 152, 1485–1492.
   Google Scholar
• HENSLEY, K., BUTTERFIELD, D. A., HALL, N., COLE, P., SUBRAMANIAM, R., MARK, R. et al., 1996, Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Annals of the New York Academy of Sciences, 786, 120–134.
   Google Scholar
• HEYMAN, A., WILKINSON, W. E., STAFFORD, J. A., HELMS, M. J., SIGMON, A. H., and WEINBERG, T., 1984, Alzheimer's disease: a study of epidemiological aspects. Annals of Neurology, 15, 335–341.
   PubMed Web of Science ®Google Scholar
• HEYMAN, A., FILLENBAUM, G. G., WELSH-BOHMER, K. A., GEARING, M., MIRRA, S. S., MOHS, R. C. et al., 1998, Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology, 51, 159–162.
   Google Scholar
• HILBICH, C., KISTERS-WOIKE, B., REED, J., MASTERS, C. L., and BEYREUTHER, K. 1991, Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. Journal of Molecular Biology, 218, 149–163.
   Google Scholar
• HILBICH, C., KISTERS-WOIKE, B., REED, J., MASTERS, C. L., and BEYREUTHER, K., 1992, Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. Journal of Molecular Biology, 228, 460–473.
   Google Scholar
• HIRAI, K., ALIEV, G., NUNOMURA, A., FUJIOKA, H., RUSSELL, R. L., ATWOOD, C. S. et al., 2001, Mitochondrial abnormalities in Alzheimer's disease. Journal of Neuroscience, 21, 3017–3023.
   Google Scholar
• HORWOOD, N., and DAVIES, D. C., 1994, Immunolabelling of hippocampal microvessel glucose trans- porter protein is reduced in Alzheimer's disease. Virchows Archiv, 425, 69–72.
   PubMed Web of Science ®Google Scholar
• HOWLAND, D. S., TRUSKO, S. P., SAVAGE, M. J., REAUME, A. G., LANG, D. M., HIRSCH, J. D. et al., 1998, Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. Journal of Biological Chemistry, 273, 16576–16582.
   Google Scholar
• HOWLETT, D. R., JENNINGS, K. H., LEE, D. C., CLARK, M. S., BROWN, F., WETZEL, R. et al., 1995, Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration, 4, 23–32.
   Google Scholar
• HOYER, S., OESTERREICH, K., and WAGNER, O., 1988, Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? Journal of Neurology, 235, 143–148.
   Google Scholar
• HUANG, X., ATWOOD, C. S., MOIR, R. D., HARTSHORN, M. A., VONSATTEL, J. P., TANZI, R. E. et al., 1997, Zinc-induced Alzheimer's Abetal-40 aggregation is mediated by conformational factors. Journal of Biological Chemistry, 272, 26464–26470.
   Google Scholar
• HUANG, X., ATWOOD, C. S., HARTSHORN, M. A., MULTHAUP, G., GOLDSTEIN, L. E., SCARPA, R. C. et al., 1999a, The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry, 38, 7609–7616.
   Google Scholar
• HUANG, X., CUAJUNGCO, M. P., ATWOOD, C. S., HARTSHORN, M. A., TYNDALL, J. D., HANSON, G. R. et al., 1999b, Cu(ii) potentiation of Alzheimer Abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. Journal of Biological Chemistry, 274, 37111–37116.
   Google Scholar
• IBARRETA, D., URCELAY, E., PARRILLA, R., and AYUSO, M. S., 1998, Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients. Annals of Neurology, 44, 216–222.
   PubMed Web of Science ®Google Scholar
• IMLAY, J. A., CHIN, S. M., and LINN, S., 1988, Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science, 240, 640–642.
   PubMed Web of Science ®Google Scholar
• INESTROSA, N. C., MARZOLO, M. P., and BONNEFONT, A. B., 1998, Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease. Molecular Neurobiology, 17, 73–86.
   PubMed Web of Science ®Google Scholar
• JAFFE, A. B., TORAN-ALLERAND, C. D., GREENGARD, P., and GANDY, S. E., 1994, Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. Journal of Biological Chemistry, 269, 13065–13068.
   Google Scholar
• JARVIK, G. P., WIJSMAN, E. M., KUKULL, W. A., SCHELLENBERG, G. D., Yu, C., and LARSON, E. B., 1995, Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology, 45, 1092–1096.
   PubMed Web of Science ®Google Scholar
• JORM, A. F., VAN DUIJN, C. M., CHANDRA, V., FRATIGLIONI, L., GRAVES, A. B., HEYMAN et al., 1991, Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Eurodem risk factors research group. International Journal of Epidemiology, 20, S43—S47.
   Google Scholar
• JUAN, S. H., and AUST, S. D., 1999, Mutational analysis of loading of iron into rat liver ferritin by ceruloplasmin. Archives of Biochemistry and Biophysics, 361, 295–301.
   PubMed Web of Science ®Google Scholar
• KALARIA, R. N., HARSHBARGER-KELLY, M., COHEN, D. L., and PREMKUMAR, D. R., 1996, Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiology of Aging, 17, 687–693.
   Google Scholar
• KALMIJN, S., LAUNER, L. J., OTT, A., WITTEMAN, J. C., HOFMAN, A., and BRETELER, M. M., 1997, Dietary fat intake and the risk of incident dementia in the Rotterdam study. Annals of Neurology, 42, 776–782.
   PubMed Web of Science ®Google Scholar
• KANG, J., LEMAIRE, H. G., UNTERBECK, A., SALBAUM, J. M., MASTERS, C. L., GRZESCHIK, K. H. et al., 1987, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 325, 733–736.
   Google Scholar
• KANOWSKI, S., HERRMANN, W. M., STEPHAN, K., WIERICH, W., and HOR RR., 1996, Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry, 29, 47–56.
   PubMed Web of Science ®Google Scholar
• KATZMAN, R., 1986, Alzheimer's disease. New England Journal of Medicine, 314, 964–973.
   PubMed Web of Science ®Google Scholar
• KATZMAN, R., TERRY, R., DETERESA, R., BROWN, T., DAVIES, P., FULD, P. et al., 1988, Clinical, patho-logical, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology, 23, 138–144.
   Google Scholar
• KEHRER, J. P., 1993, Free radicals as mediators of tissue injury and disease. Critical Reviews in Toxicology, 23, 21–48.
   PubMed Web of Science ®Google Scholar
• KITAGUCHI, N., TAKAHASHI, Y., TOKUSHIMA, Y., SHIOJIRI, S., and ITo, H., 1988, Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature, 331, 530–532.
   PubMed Web of Science ®Google Scholar
• KLAIBER, E. L., BROVERMAN, D. M., VOGEL, W., KOBAYASHI, Y., 1979, Estrogen therapy for severe persistent depressions in women. Archives of General Psychiatry, 36, 550–554.
   PubMed Web of Science ®Google Scholar
• KOH, J. Y., 2001, Zinc and disease of the brain. Molecular Neurobiology, 24, 99–106.
   PubMed Web of Science ®Google Scholar
• KOX, J. Y., YANG, L. L., and COTMAN, C. W., 1990, Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Research, 533, 315–320.
   PubMed Web of Science ®Google Scholar
• KOKMEN, E., BEARD, C. M., CHANDRA, V., OFFORD, K. P., SCHOENBERG, B. S., and BALLARD, D. J., 1991, Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology, 41, 1393–1397.
   PubMed Web of Science ®Google Scholar
• KOLSCH, H., LUDWIG, M., LUTJOHANN, D., and RAO, M. L., 2001, Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradio1-17beta. Journal of Neural Transmission, 108, 475–488.
   PubMed Web of Science ®Google Scholar
• KOO, E. H., and SQUAZZO, S. L., 1994, Evidence that production and release of amyloid beta-protein involves the endocytic pathway. Journal of Biological Chemistry, 269, 17386–17389.
   PubMed Web of Science ®Google Scholar
• KOWALTOWSKI, A. J., and VERCESI, A. E., 1999, Mitochondrial damage induced by conditions of oxida-tive stress. Free Radical Biology and Medicine, 26, 463–471.
   PubMed Web of Science ®Google Scholar
• LAWS, S. M., HONE, E., TADDEI, K., HARPER, C., DEAN, B., MCCLEAN, C., MASTERS, C., LAUTENSCHLAGER, N., GANDY, S. E. and MARTINS, R. N., 2002, Variation at the apoe —491 promoter locus is associated with altered brain levels of apolipoprotein e. Mol Psychiatry, 7, 886–890.
   PubMed Web of Science ®Google Scholar
• LAWS, S. M., TADDEI, K., MARTINS, G., PATON, A., FISHER, C., CLARNETTE, R. et al., 1999, The —491AA polymorphism in the ApoE gene is associated with increased plasma ApoE levels in Alzheimer's disease. NeuroReport, 10, 879–882.
   Google Scholar
• LE BARS, P. L., KIESER, M., and ITiL, K. Z., 2000, A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract Egb 761 in dementia. Dementia and Geriatric Cognitive Disorders, 11, 230–237.
   PubMed Web of Science ®Google Scholar
• LEHTONEN, A., and LUUTONEN, S., 1986, High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia. Age and Ageing, 15, 267–270.
   PubMed Web of Science ®Google Scholar
• LEVY-LAHAD, E., LAHAD, A., WIJSMAN, E. M., BIRD, T. D., and SCHELLENBERG, G. D., 1995, Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Annals of Neurology, 38, 678–680.
   Google Scholar
• LIM, G. P., CHU, T., YANG, F., BEECH, W., FRAUTSCHY, S. A., and COLE, G. M., 2001, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience, 21, 8370–8377.
   PubMed Web of Science ®Google Scholar
• LOCKHART, B. P., BENICOURT, C., JUNIEN, J. L., and PRIVAT, A., 1994, Inhibitors of free radical forma-tion fail to attenuate direct beta-amyloid 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. Journal of Neuroscience Research, 39, 494–505.
   PubMed Web of Science ®Google Scholar
• LOPEZ, M. F., and MELOV, S., 2002, Applied proteomics: mitochondrial proteins and effect on function. Circulation Research, 90, 380–389.
   PubMed Web of Science ®Google Scholar
• LORENZO, A., and YANKNER, B. A., 1994, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proceedings of the National Academy of Sciences USA, 91, 12243–12247.
   PubMed Web of Science ®Google Scholar
• LUGASI, A., HORVAHOVICH, P., and DWORSCHAK, E., 1999, Additional information to the in vitro anti- oxidant activity of ginkgo biloba 1. Phytotherapy Research, 13, 160–162.
   PubMed Web of Science ®Google Scholar
• MABROUK, A. F., and DUGAN, L. R., 1960, A kinetic study of the autoxidation of methyl linoleate and linoleic acid emulsions in the presence of sodium chloride. Journal of the American Oil Chemists' Society, 37, 486–490.
   Web of Science ®Google Scholar
• MANTYH, P. W., GHILARDI, J. R., ROGERS, S., DEMASTER, E., ALLEN, C. J., STIMSON, E. R. et al., 1993, Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. Journal of Neurochemistry, 61, 1171–1174.
   Google Scholar
• MARK, R. J., PANG, Z., GEDDES, J. W., UCHIDA, K., and MATTSON, M. P., 1997, Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. Journal of Neuroscience, 17, 1046–1054.
   PubMed Web of Science ®Google Scholar
• MARKESBERY, W. R., 1997, Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology and Medicine, 23, 134–147.
   PubMed Web of Science ®Google Scholar
• MARKESBERY, W. R., and EHMANN, W. D., 1994, Brain trace elements in Alzheimer's disease. In Alzheimer's Disease, edited by R. D. Terry, R. Katzman and K. L. Bick (New York: Raven), pp. 353–367.
   Google Scholar
• MARTINS, R. N., HARPER, C. G., STOKES, G. B., and MASTERS, C. L., 1986, Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. Journal of Neurochemistry, 46, 1042–1045.
   PubMed Web of Science ®Google Scholar
• MARTINS, R. N., CLARNETTE, R., FISHER, C., BROE, G. A., BROOKS, W. S., MONTGOMERY, P. et al., 1995, ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport, 6, 1513–1516.
   Google Scholar
• MASSAFRA, C., GIOIA, D., DE FELICE, C., PICCIOLINI, E., DE LEO, V., BONIFAZI, M. etal., 2000, Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and gluta- thione peroxidase activities during the menstrual cycle. Journal of Endocrinology, 167, 447–452.
   PubMed Web of Science ®Google Scholar
• MASTERS, C. L., Simms, G., w — EINMAN, N. A., MULTHAUP, G., MCDONALD, B. L., and BEYREUTHER, K., 1985, Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences USA, 82, 4245–4249.
   Google Scholar
• MATTSON, M. P., 1990, Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2± influx in cultured hippocampal neurons. Neuron, 4, 105–117.
   PubMed Web of Science ®Google Scholar
• MATTSON, M. P., 1995, Untangling the pathophysiochemistry of beta-amyloid. Nature Structural Biology, 2, 926–928.
   PubMedGoogle Scholar
• MATTSON, M. P., 1997, Central role of oxyradicals in the mechanism of amyloid beta-peptide cytotoxicity. Alzheimer Disease Review, 2, 1–14.
   Google Scholar
• MATTSON, M. P., 2000, Existing data suggest that Alzheimer's disease is preventable. Annals of the New York Academy of Sciences, 924, 153–159.
   PubMed Web of Science ®Google Scholar
• MATTSON, M. P., BARGER, S. W., CHENG, B., LIEBURG, I., SMITH-SWINTOSKY, L., V. and RYDEL, R. E., 1993, Beta amyloid precursor protein metabolites and loss of neuronal ca2+ homeostasis in alzheimer's disease. Tins, 16, 409–414.
   Google Scholar
• MATTSON, M. P., CHENG, B., DAVIS, D., BRYANT, K., LIEBERBURG, I., and RYDEL, R. E., 1992, Beta-amyloid peptides destabilise calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience, 12, 376–389.
   PubMed Web of Science ®Google Scholar
• MATTSON, M. P., LOVELL, M. A., FURUKAWA, K., and MARKESBERY, W. R., 1995, Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2± concentra-tion, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. Journal of Neurochemistry, 65, 1740–1751.
   PubMed Web of Science ®Google Scholar
• MATTSON, M. P., Guo, Q., FURUKAWA, K., and PEDERSEN, W. A., 1998, Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. Journal of Neurochemistry, 70, 1–14.
   PubMed Web of Science ®Google Scholar
• MATTSON, M. P., DUAN, W., LEE, J., and Guo, Z., 2001a, Suppression of brain aging and neurodegen-erative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mechanisms of Ageing and Development, 122, 757–778.
   PubMed Web of Science ®Google Scholar
• MATTSON, M. P., DUAN, W., PEDERSEN, W. A., and CULMSEE, C., 2001b, Neurodegenerative disorders and ischemic brain diseases. Apoptosis, 6, 69–81.
   PubMed Web of Science ®Google Scholar
• MAURER, K., lin., R., DIERKS, T., and FROLICH, L., 1997, Clinical efficacy of ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. Journal of Psychiatric Research, 31, 645–655.
   Google Scholar
• MCCAY, P. B., 1985, Vitamin E: interactions with free radicals and ascorbate. Annual Review of Nutrition, 5, 323–340.
   PubMed Web of Science ®Google Scholar
• MCEWEN, B. S., ALVES, S. E., BULLOCH, K., and WEILAND, N. G., 1997, Ovarian steroids and the brain: implications for cognition and aging. Neurology, 48 (Suppl. 7), S8—S15.
   Google Scholar
• MCGEER, P. L., and MCGEER, E. G., 2001, Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Archives of Neurology, 58, 1790–1792.
   PubMed Web of Science ®Google Scholar
• MILLER, D. L., PAPAYANNOPOULOS, I. A., STYLES, J., BOBIN, S. A., LIN, Y. Y., BIEMANN, K. et al., 1993, Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Archives of Biochemistry and Biophysics, 301, 41–52.
   Google Scholar
• MIRANDA, S., OPAZO, C., LARRONDO, L. F., MUNOZ, F. J., Ruiz, F., LEIGHTON, F. et al., 2000, The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Progress in Neurobiology, 62, 633–648.
   Google Scholar
• MISONOU, H., MORISHIMA-KAWASHIMA, M., and IHARA, Y., 2000, Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry, 39, 6951–6959.
   PubMed Web of Science ®Google Scholar
• MIYATA, M., and SMITH, J. D., 1996, Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nature Genetics, 14, 55–61.
   PubMed Web of Science ®Google Scholar
• MONTINE, T. J., MARICESBERY, W. R., MORROW, J. D., and ROBERTS, L. J., II, 1998, Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Annals of Neurology, 44, 410–413.
   Google Scholar
• MORRIS, M. C., EVANS, D. A., BIENIAS, J. L., TANGNEY, C. C., BENNETT, D. A., AGGARWAL, N. et al., 2002, Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. Journal of the American Medical Association, 287, 3230–3237.
   Google Scholar
• MULTHAUP, G., RUPPERT, T., SCHLICKSUPP, A., HESSE, L., BILL, E., PIPKORN, R. et al., 1998, Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry, 37, 7224–7230.
   Google Scholar
• MUNCH, G., Simm, A., DOUBLE, K. L., and RIEDERER, P., 1996, Oxidative stress and advanced glycation endproducts—parts of a vicious circle of neurodegeneration. Alzheimer's Disease Reviews, 1, 71–74.
   Google Scholar
• MURRELL, J., FARLOW, M., GHETTI, B., and BENSON, M. D., 1991, A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 254, 97–99.
   PubMed Web of Science ®Google Scholar
• MUSCI, G., BONACCORSI DI PATTI, M. C., and CALABRESE, L., 1993a, The state of the copper sites in human ceruloplasmin. Archives of Biochemistry and Biophysics, 306, 111–118.
   PubMed Web of Science ®Google Scholar
• MUSCI, G., BONACCORSI DI PATTI, M. C., FAGIOLO, U., and CALABRESE, L., 1993b, Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. Journal of Biological Chemistry, 268, 13388–13395.
   PubMed Web of Science ®Google Scholar
• NAGY, Z., ESIRI, M. M., JOBST, K. A., MORRIS, J. H., KING, E. M., MCDONALD, B. et al., 1997, The effects of additional pathology on the cognitive deficit in Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 56, 165–170.
   Google Scholar
• NUNOMURA, A., PERRY, G., HIRAI, K., ALIEV, G., TAICEDA, A., CHIBA, S. et al., 1999, Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Annals of the New York Academy of Sciences, 893, 362–364.
   Google Scholar
• NUNOMURA, A., PERRY, G., PAPPOLLA, M. A., FRIEDLAND, R. P., HIRAI, K., CHIBA, S. et al., 2000, Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. Journal of Neuropathology and Experimental Neurology, 59, 1011–1017.
   Google Scholar
• NUNOMURA, A., PERRY, G., ALIEV, G., HIRAI, K., TAKEDA, A., BALRAJ, E. K. et al., 2001, Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 60, 759–767.
   Google Scholar
• OHKURA, T., IssE, K., AKAZAWA, K., HAMAMOTO, M., YAOI, Y., HAGINO, N., 1995, Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia, 6, 99–107.
   PubMedGoogle Scholar
• OKEN, B. S., STORZBACH, D. M., and KAYE, J. A., 1998, The efficacy of ginkgo biloba 011 cognitive function in Alzheimer disease. Archives of Neurology, 55, 1409–1415.
   PubMed Web of Science ®Google Scholar
• OLIVIERI, G., NOVAKOVIC, M., SAVASKAN, E., MEIER, F., BAYSANG, G., BROCKHAUS, M. et al., 2002, The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience, 113, 849–855.
   Google Scholar
• OTT, A., BRETELER, M. M., VAN HARSKAMP, F., CLAUS, J. J., VAN DER CAMMEN, T. J., GROBBEE, D. E. et al., 1995, Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ, 310, 970–973.
   Google Scholar
• PACKER, L., RIMBACH, G., and VIRGILI, F., 1999, Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radical Biology and Medicine, 27, 704–724.
   PubMed Web of Science ®Google Scholar
• PALSSON, S., AEVARSSON, O., and SKOOG, I., 1999, Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds. British Journal of Psychiatry, 174, 249–253.
   PubMed Web of Science ®Google Scholar
• PAPPOLLA, M. A., CHYAN, Y. J., POEGGELER, B., FRANGIONE, B., WILSON, G., OHISO, J. et al., 2000, An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. Journal of Neural Transmission ( Budapest), 107, 203–231.
   Google Scholar
• PASINETTI, G. M., 2002, From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. Journal of Alzheimer's Disease, 4, 435–445.
   PubMed Web of Science ®Google Scholar
• PENG, Q. L., BUZ'ZARD, A. R., and LAU, B. H., 2002, Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis. Brain Research. Molecular Brain Research, 104, 55–65.
   Google Scholar
• PERRY, E. K., PERRY, R. H., and TOMLINSON, B. E., 1982, The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neuroscience Letters, 29, 303–307.
   PubMed Web of Science ®Google Scholar
• PERRY, G., RAINA, A. K., NUNOMURA, A., WATAYA, T., SAYRE, L. M., and SMITH, M. A., 2000, How important is oxidative damage? Lessons from Alzheimer's disease. Free Radical Biology and Medicine, 28, 831–834.
   PubMed Web of Science ®Google Scholar
• PETANCESKA, S. S., NAGY, V., FRAIL, D., and GANDY, S., 2000, Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology, 54, 2212–2217.
   PubMed Web of Science ®Google Scholar
• PIKE, C. J., WALENCEWICZ, A. J., OLABE, C. G., and COTMAN, C. W., 1991, In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Research, 563, 311–314.
   PubMed Web of Science ®Google Scholar
• PIKE, C. J., BURDICK, D., WALENCEWICZ, A. J., OLABE, C. G., and COTMAN, C. W., 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. Journal of Neuroscience, 13, 1676–1687.
   PubMed Web of Science ®Google Scholar
• PILLOT, T., ODETHALS, M., VANLOO, B., TALUSSOT, C., BRASSEUR, R., VANDEKERCICHOVE, J. et al., 1996, Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. Journal of Biological Chemistry, 271, 28757–28765.
   Google Scholar
• POLYAK, K., XIA, Y., ZWEIER, J. L., KINZLER, K. W., and VOGELSTEIN, B., 1997, A model for p53-induced apoptosis. Nature, 389, 300–305.
   PubMed Web of Science ®Google Scholar
• PRATICO, D., 2002, Alzheimer's disease and oxygen radicals: new insights. Biochemical Pharmacology, 63, 563–567.
   PubMed Web of Science ®Google Scholar
• PRATICO, D., TANGIRALA, R. K., RADER, D. J., ROKACH, J., and FITZGERALD, G. A., 1998, Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nature Medicine, 4, 1189–1192.
   PubMed Web of Science ®Google Scholar
• PRATICO, D., URYU, K., LEIGHT, S., TROJANOSWKI, J. Q., LEE, V. M., 2001, Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. Journal of Neuroscience, 21, 4183–4187.
   PubMed Web of Science ®Google Scholar
• PRELLI, F., CASTANO, E., OLENNER, G. G., and FRANGIONE, B., 1988, Differences between vascular and plaque core amyloid in Alzheimer's disease. Journal of Neurochemistry, 51, 648–651.
   PubMed Web of Science ®Google Scholar
• PRYOR, W. A., 1982, Free radical biology: xenobiotics, cancer, and aging. Annals of the New York Academy of Sciences, 393, 1–22.
   PubMed Web of Science ®Google Scholar
• PRYOR, W. A., 1986, Oxy-radicals and related species: their formation, lifetimes, and reactions. Annual Review of Physiology, 48, 657–667.
   PubMed Web of Science ®Google Scholar
• PUTTAPARTHI, K., GITOMER, W. L., KRISHNAN, U., SON, M., RAJENDRAN, B., and ELLIOTT, J. L., 2002, Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. Journal of Neuroscience, 22, 8790–8796.
   PubMed Web of Science ®Google Scholar
• PUERFURTH, H. W., WIJSMAN, E. M., ST GEORGE-HYSLOP, P. H., and SELKOE, D. J., 1995, Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Brain Research. Molecular Brain Research, 28, 319–337.
   Google Scholar
• RASMUSSON, D. X., BRANDT, J., MARTIN, D. B., and FOLSTEIN, M. F., 1995, Head injury as a risk factor in Alzheimer's disease. Brain Injury, 9, 213–219.
   PubMed Web of Science ®Google Scholar
• REBECK, G. W., REITER, J. S., STRICKLAND, D. K. and HYMAN, B. T., 1993, Apolipoprotein e in sporadic alzheimer's disease: Allelic variation and receptor interactions. Neuron, 11, 575–580.
   PubMed Web of Science ®Google Scholar
• REILLY, C. A., and AUST, S. D., 1997, Stimulation of the ferroxidase activity of ceruloplasmin during iron loading into ferritin. Archives of Biochemistry and Biophysics, 347, 242–248.
   PubMed Web of Science ®Google Scholar
• REITER, R. J., 1998, Oxidative damage in the central nervous system: protection by melatonin. Progress in Neurobiology, 56, 359–384.
   PubMed Web of Science ®Google Scholar
• ROHER, A. E., BALL, M. J., BHAVE, S. V., and WAKADE, A. R., 1991a, Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochemical and Biophysical Research Communications, 174, 572–579.
   PubMed Web of Science ®Google Scholar
• ROHER, A. E., PALMER, K. C., CAPODILUPO, J., WAKADE, A. R., and BALL, M. J., 1991b, New biochem-ical insights to unravel the pathogenesis of Alzheimer's lesions. Canadian Journal of Neurological Sciences, 18, 408–410.
   PubMed Web of Science ®Google Scholar
• ROMANO, C., PETTINATO, R., RAGUSA, L., BARONE, C., ALBERTI, A., and FAILLA, P., 2002, Is there a relationship between zinc and the peculiar comorbidities of Down syndrome? Down's Syndrome. Research and Practice, 8, 25–28.
   Google Scholar
• RYDEN, L., and EAKER, D., 1983, Identification of the thiol groups in human ceruloplasmin. European Journal of Biochemistry, 132, 241–247.
   PubMedGoogle Scholar
• SANO, M., ERNESTO, C., THOMAS, R. G., KLAUBER, M. R., SCHAFER, K., GRUNDMAN, M. et al., 1997, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study [see comments]. New England Journal of Medicine, 336, 1216–1222.
   Google Scholar
• SAYRE, L. M., ZELASKO, D. A., HARRIS, P. L., PERRY, G., SALOMON, R. G., and SMITH, M. A., 1997, 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. Journal of Neurochemistry, 68, 2092–2097.
   PubMed Web of Science ®Google Scholar
• SCHAFER, F. Q., and BUETTNER, G. R., 2000, Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radical Biology and Medicine, 28, 1175–1181.
   PubMed Web of Science ®Google Scholar
• SCHEUNER, D., ECKMAN, C., JENSEN, M., SONG, X., CITRON, M., SUZUKI, N. et al., 1996, Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Medicine, 2, 864–870.
   Google Scholar
• SCHUBERT, D., and CHEVION, M., 1995, The role of iron in beta amyloid toxicity. Biochemical and Biophysical Research Communications, 216, 702–707.
   PubMed Web of Science ®Google Scholar
• SELKOE, D. J., 1996, Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease. Cold Spring Harbour Symposia on Quantitative Biology, 61, 587–596.
   PubMedGoogle Scholar
• SHEARMAN, M. S., RAGAN, C. I., and IVERSEN, L. L., 1994, Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proceedings of the National Academy of Sciences USA, 91, 1470–1474.
   PubMed Web of Science ®Google Scholar
• SHERRINGTON, R., ROGAEV, E. I., LIANG, Y., ROGAEVA, E. A., LEVESQUE, G., IKEDA, M. et al., 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375, 754–760.
   Google Scholar
• SIMMONS, L. K., MAY, P. C., TOMASELLI, K. J., RYDEL, R. E., FUSON, K. S., BRIGHAM, E. F. et al., 1994, Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Molecular Pharmacology, 45, 373–379.
   Google Scholar
• SIMONS, M., KELLER, P., DE STROOPER, B., BEYREUTHER, K., DOTTI, C. G., and SIMONS, K., 1998, Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proceedings of the National Academy of Sciences USA, 95, 6460–6464.
   PubMed Web of Science ®Google Scholar
• SIMPKINS, J. W., GREEN, P. S., GRIDLEY, K. E., SINGH, M., DE FIEBRE, N. C., and RAJAKUMAR, G., 1997, Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. American Journal of Medicine, 103, 19S–25S.
   Google Scholar
• SIMPSON, I. A., CHUNDU, K. R., DAVIES-HILL, T., HONER, W. G., and DAVIES, P., 1994, Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Annals of Neurology, 35, 546–551.
   Google Scholar
• SKOOG, I., 1998, A review on blood pressure and ischaemic white matter lesions. Dementia and Geriatric Cognitive Disorders, 9, 13–19.
   PubMed Web of Science ®Google Scholar
• SMITH, C., MITCHINSON, M. J., ARUOMA, O. I. and HALLIWELL, B., 1992, Stimulation of lipid peroxida-tion and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J, 286, 901–905.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., and PERRY, G., 1997a, The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. Journal of Neuropathology and Experimental Neurology, 56, 217.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., and PERRY, G., 1997b, Oxidative stress is central to the pathogenesis of Alzheimer disease (Alzheimer's International Internet Conference). http://www.a/zforum.org/res/for/perryl/ Oxstress.asp
   Google Scholar
• SMITH, M. A., KUTTY, R. K., RICHEY, P. L., YAN, S. D., STERN, D., CHADER, G. J. et al., 1994a, Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. American Journal of Pathology, 145, 42–47.
   Google Scholar
• SMITH, M. A., RICHEY, P. L., TANEDA, S., KUTTY, R. K., SAYRE, L. M., MONNIER, V. M. et al., 1994b, Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Annals of the New York Academy of Sciences, 738, 447–454.
   Google Scholar
• SMITH, M. A., RUDNICKA-NAWROT, M., RICHEY, P. L., PRAPROTNIK, D., MULVIHILL, P., MILLER, C. A. et al., 1995a, Carbonyl-related post-translational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. Journal of Neurochemistry, 64, 2660–2666.
   Google Scholar
• SMITH, M. A., Sayre, L. M., MONNIER, V. M. and Perry, G., 1995c, Radical ageing in alzheimer's disease. Trends in Neurosciences, 18, 172–176.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., SAYRE, L. M., VITEK, M. P., MONNIER, V. M., and PERRY, G., 1995b, Early ageing and Alzheimer's. Nature, 374, 316.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., PERRY, G., RICHEY, P. L., SAYRE, L. M., ANDERSON, V. E., BEAL, M. F. et al., 1996a, Oxidative damage in Alzheimer's. Nature, 382, 120–121.
   Google Scholar
• SMITH, M. A., SIEDLAK, S. L., RICHEY, P. L., NAGARAJ, R. H., ELHAMMER, A., and PERRY, G., 1996b, Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease. Brain Research, 717, 99–108.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., HARRIS, P. L., SAYRE, L. M., and PERRY, G., 1997a, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proceedings of the National Academy of Sciences USA, 94, 9866–9868.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., RICHEY HARRIS, P. L., SAYRE, L. M., BECKMAN, J. S., and PERRY, G., 1997b, Widespread peroxynitrite-mediated damage in Alzheimer's disease. Journal of Neuroscience, 17, 2653–2657.
   PubMed Web of Science ®Google Scholar
• SMITH, M. A., CASADESUS, G., JOSEPH, J. A., and PERRY, G., 2002, Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radical Biology and Medicine, 33, 1194–1199.
   PubMed Web of Science ®Google Scholar
• SOUTHORN, P. A., and Pow's, G., 1988a, Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clinic Proceedings, 63, 381–389.
   Google Scholar
• SOUTHORN, P. A., and Pow's, G., 1988b, Free radicals in medicine. II. Involvement in human disease. Mayo Clinic Proceedings, 63, 390–408.
   Google Scholar
• SPARKS, D. L., HUNSAKER, J. C., III, SCHEFF, S. W., KRYSCIO, R. J., HENSON, J. L., and MARKESBERY, W. R., 1990, Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiology of Aging, 11, 601–607.
   Google Scholar
• STRITTMATTER, W. J., SAUNDERS, A. M., SCHMECHEL, D., PERICAK-VANCE, M., ENGHILD, J., SALVESEN, G. S. et al., 1993, Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences USA, 90, 1977–1981.
   Google Scholar
• STUDER, R., BAYSANG, G., and BRACK, C., 2001, N-Acetyl-L-cystein downregulates beta-amyloid precursor protein gene transcription in human neuroblastoma cells. Biogerontology, 2, 55–60.
   PubMed Web of Science ®Google Scholar
• SU, Y., and CHANG, P. T., 2001, Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide. Brain Research, 893, 287–291.
   PubMed Web of Science ®Google Scholar
• SULKAVA, R., 1998, Anti-inflammatory drug therapy for prevention of Alzheimer's disease? Duodecim, 114, 2025–2027.
   Google Scholar
• SUZUKI, N., CHEUNG, T. T., CAI, X. D., ODAKA, A., OTVOS, L., JR, ECKMAN, C. et al., 1994, An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science, 264, 1336–1340.
   Google Scholar
• TANZI, R. E., GUSELLA, J. F., WATKINS, P. C., BRUNS, G. A., ST GEORGE-HYSLOP, P., VAN KEUREN, M. L. et al., 1987, Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 235, 880–884.
   Google Scholar
• TANZI, R. E., MCCLATCHEY, A. I., LAMPERTI, E. D., VILLA-KOMAROFF, L., GUSELLA, J. F., and NEVE, R. L., 1988, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature, 331, 528–530.
   Google Scholar
• TATEMICHI, M., NAGATA, H., SEKIZUKA, E., MORISHITA, T., MIYAIRI, M., TSUCHIYA, M. et al., 1996, Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy. Digestive Diseases and Sciences, 41, 562–570.
   Google Scholar
• TELLER, J. K., Russo, C., DEBUSK, L. M., ANGELINI, G., ZACCHEO, D., DAGNA-BRICARELLI, F. et al., 1996, Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nature Medicine, 2, 93–95.
   Google Scholar
• THOMAS, T., THOMAS, G., MCLENDON, C., SUTTON, T., and MULLAN, M., 1996, Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature, 380, 168–171.
   PubMed Web of Science ®Google Scholar
• TORSDOTTIR, G., KRISTINSSON, J., SVEINBJORNSDOTTIR, S., SNAEDAL, J., and JOHANNESSON, T., 1999, Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacology and Toxicology, 85, 239–243.
   PubMedGoogle Scholar
• UCHIDA, S., EDAMATSU, R., HIRAMATSU, M., MORI, A., NONAKA, G., NISHIOKA, I. et al., 1987, Condensed tannins scavenge active oxygen free radicals. Medical Science Research, 15, 831–832.
   Google Scholar
• VARADARAJAN, S., YATIN, S., AKSENOVA, M., and BUTTERFIELD, D. A., 2000, Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. Journal of Structural Biology, 130, 184–208.
   PubMed Web of Science ®Google Scholar
• VEURINK, G., Liu, D., TADDEI, K., PERRY, G., SMITH, M. A., ROBERTSON, T. A. et al., 2003, Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radical Biology and Medicine, 34, 1070–1077.
   Google Scholar
• VINCENT, B., and SMITH, J. D., 2000, Effect of estradiol on neuronal Swedish-mutated beta-amyloid precursor protein metabolism: reversal by astrocytic cells. Biochemical and Biophysical Research Communications, 271, 82–85.
   PubMed Web of Science ®Google Scholar
• VOLICER, L., and CRINO, P. B., 1990, Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiology of Aging, 11, 567–571.
   PubMed Web of Science ®Google Scholar
• WADDINGTON, E., CROFT, K., CLARNETTE, R., MORI, T., and MARTINS, R., 1999, Plasma F2-isoprostane levels are increased in Alzheimer's disease: evidence of increased oxidative stress in vivo. Alzheimer's Reports, 2, 277–282.
   Google Scholar
• WALKER, D. G., LUE, L. F., and BEACH, T. G., 2002, Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains. Brain Research, 926, 69–79.
   PubMed Web of Science ®Google Scholar
• WESTBROOK, G. L., and MAYER, M. L., 1987, Micromolar concentrations of Zn2± antagonise NMDA and GABA responses of hippocampal neurons. Nature, 328, 640–643.
   PubMed Web of Science ®Google Scholar
• WETTSTEIN, A., 2000, Cholinesterase inhibitors and gingko extracts-are they comparable in the treat-ment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine, 6, 393–401.
   PubMed Web of Science ®Google Scholar
• WHITE, L. R., PETROVITCH, H., Ross, G. W., MASAKI, K., IZMURLIAN, G., FOLEY, D. et al., 1998, Rates, characteristics, and risk factors for dementia among Japanese-American men in Honolulu Comparisons with other Japanese- and European-ancestry populations. Neurobiology of Aging, 19 (Suppl. 4), S200.
   Google Scholar
• WHITSON, J. S., SELKOE, D. J., and COTMAN, C. W., 1989, Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science, 243, 1488–1490.
   PubMed Web of Science ®Google Scholar
• WILLS, E. D., 1965, Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acids. Biochimica et Biophysica Acta, 98, 238–251.
   PubMed Web of Science ®Google Scholar
• WILLS, E. D., 1966, Mechanisms of lipid peroxide formation in animal tissues. Biochemical Journal, 99, 667–676.
   PubMed Web of Science ®Google Scholar
• WINTHER, K., RANDLOV, C., REIN, E., and MEHLSEN, J., 1998, Effects of ginkgo biloba extract 011 cognitive function and blood pressure in elderly subjects. Current Therapeutic Research, Clinical and Experimental, 59, 881–888.
   Web of Science ®Google Scholar
• WISNIEWSKI, K. E., LAURE-KAMIONOWSKA, M., and WISNIEWSKI, H. M., 1984, Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. New England Journal of Medicine, 311, 1187–1188.
   Google Scholar
• WISNIEWSKI, K. E., WISNIEWSKI, H. M., and WEN, G. Y., 1985, Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Annals of Neurology, 17, 278–282.
   PubMed Web of Science ®Google Scholar
• WISNIEWSKI, T., LALOWSKI, M., LEVY, E., MARQUES, M. R., and FRANGIONE, B., 1994, The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient. Annals of Neurology, 35, 245–246.
   PubMed Web of Science ®Google Scholar
• WISNIEWSKI, T., GHISO, J., and FRANGIONE, B., 1997, Biology of A beta amyloid in Alzheimer's disease. Neurobiology of Disease, 4, 313–328.
   PubMed Web of Science ®Google Scholar
• XIE, L., HELMERHORST, E., TADDEI, K., PLEWRIGHT, B., VAN BRONSWIJK, W., and MARTINS, R., 2002, Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. Journal of Neuroscience, 22, RC221.
   Google Scholar
• XU, H., GOURAS, G.K., GREENFIELD, J. P., VINCENT, B., NASLUND, J., MAZZARELLI, L. et al., 1998, Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nature Medicine, 4, 447–451.
   Google Scholar
• YAMAGUCHI, H., SUGIHARA, S., OGAWA, A., OSHIMA, N., and IHARA, Y., 2001, Alzheimer beta amyloid deposition enhanced by ApoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. Journal of Neuropathology and Experimental Neurology, 60, 731–739.
   PubMed Web of Science ®Google Scholar
• YANG, D. S., SMITH, J. D., ZHOU, Z., GANDY, S. E., and MARTINS, R. N., 1997, Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 iso-forms and to isoforms from human plasma. Journal of Neurochemistry, 68, 721–725.
   PubMed Web of Science ®Google Scholar
• YANKNER, B. A., 1996, Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 16, 921–932.
   PubMed Web of Science ®Google Scholar
• YANKNER, B. A., CACERES, A., and DUFFY, L. K., 1990a, Nerve growth factor potentiates the neurotoxi- city of beta amyloid. Proceedings of the National Academy of Sciences USA, 87, 9020–9023.
   PubMed Web of Science ®Google Scholar
• YANKNER, B. A., DUFFY, L. K., and KIRSCHNER, D. A., 1990b, Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science, 250, 279–282.
   PubMed Web of Science ®Google Scholar
• YANKNER, B. A., DAWES, L. R., FISHER, S., VILLA-KOMAROFF, L., OSTER-GRANITE, M. L., and NEVE, R. L., 1989, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science, 245, 417–420.
   Google Scholar
• YATES, C. M., BUTTERWORTH, J., TENNANT, M. C., and GORDON, A., 1990, Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. Journal of Neurochemistry, 55, 1624–1630.
   PubMed Web of Science ®Google Scholar
• YOSHIKAWA, K., AIZAWA, T., and HAYASHI, Y., 1992, Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature, 359, 64–67.
   PubMed Web of Science ®Google Scholar
• ZAMZAMI, N., HIRSCH, T., DALLAPORTA, B., PETIT, P. X., and KROEMER, G., 1997, Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. Journal of Bioenergetics and Biomembranes, 29, 185–193.
   PubMed Web of Science ®Google Scholar
• ZHANG, P., Liu, B., KANG, S. W., SEO, M. S., RHEE, S. G., and OBEID, L. M., 1997, Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bc1-2. Journal of Biological Chemistry, 272, 30615–30618.
   PubMed Web of Science ®Google Scholar
• ZUU, H., Guo, Q., and MATTSON, M. P., 1999, Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Research, 842, 224–229.
   PubMed Web of Science ®Google Scholar